Research and Development

Showing 15 posts of 9603 posts found.

peter_farrell

QRxPharma announces several resignations

July 11, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Campbell, PACE, QRxPharma, farrell, quinn

Australian pharma development firm QRxPharma has confirmed that its chairman Dr Peter Farrell and director Dr Gary Pace have resigned. …
ema image

EMA delays trial transparency – again

July 10, 2014 Medical Communications, Research and Development, Sales and Marketing EMA, Goldacre, Rasi, alltrials, clinical trials, transparency

The European Medicines Agency has once again said that it is to delay the launch of its new clinical trial …
richard_bungay_photography_by_alan_hillyer

Glide Pharma makes two senior hires

July 10, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Glide Pharma, Richard Bungay, Tony Mills

Oxford-based development and device firm Glide Pharma has appointed Richard Bungay as its chief financial officer (CFO) and Dr Tony …

Boehringer blood cancer drug scores in Phase II

July 9, 2014 Research and Development, Sales and Marketing Boehringer, blood, giotrif, leukaemia, volasertib

Less than a year after securing its first cancer drug on the market with Giotrif, Boehringer has taken another decisive …
sarah_newman

Clark Health Communications hires account director

July 9, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clark Health Communications, chc, newman

Clark Health Communications (CHC) has recruited account director Sarah Newman as its first full-time employee to help manage the agency’s …

Cameron’s antibiotics plan not enough

July 8, 2014 Research and Development, Sales and Marketing Antibiotics, BBC, NHS, UK, david cameron, governement

UK prime minister David Cameron’s reaction to antibiotic resistance is not urgent enough and doctors are continuing to prescribe antibiotics …
BMS image

World’s first anti-PD-1 therapy approved

July 8, 2014 Research and Development, Sales and Marketing BMS, Cancer, melanoma, nivolumab, ono, opdivo

Ono Pharmaceutical has been given the world’s first licence for a new type of cancer treatment on which many researchers’ …
ian_dodge_nhs

New appointments at NHS England

July 8, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing DoH, NHS Commissioning, NHS England, stevens

NHS England chief executive Simon Stevens has confirmed a number of senior appointments to the organisation. Dr Mahiben Maruthappu has …
marie_innes_1

New director for Cello Health Insight

July 8, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, Kantar Health, marie innes

Healthcare market research agency Cello Health Insight has appointed Marie Innes as director. Based in the firm’s London head office …
amy_schulman_alynlam

Alynlam secures fomer Pfizer head

July 7, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, alynlam, amy schulman

US biotech firm Alynlam has elected Pfizer’s former executive VP and general counsel Amy Schulman to its board of directors. …
FDA image

Spectrum wins FDA approval for rare cancer drug

July 4, 2014 Research and Development, Sales and Marketing Beleodaq, Cancer, FDA, Spectrum, non-Hodgkin lymphoma

In an expedited review the FDA has approved a new cancer drug from Spectrum Pharmaceuticals to treat a rare cancer …
ann-tove_kongsnes_

Pharmalink elects three to board

July 4, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ann-Tove Kongsnes, Hilde Furberg, Olav Hellebø, Pharmalink, ab

Swedish speciality pharma firm Pharmalink AB has appointed Ann-Tove Kongsnes, Hilde Furberg and Olav Hellebø to its board of directors. …
annalisa_prosensa

Prosensa makes two key appointments



July 3, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Prosensa, Willem W. van Weperen. Annalisa Jenkins

Dutch biopharma firm Prosensa has appointed Willem W. van Weperen as chief commercial officer and Dr Annalisa Jenkins to its …

World facing medical ‘dark ages’ over antibiotic resistance

July 2, 2014 Medical Communications, Research and Development, Sales and Marketing Antibiotics, BRIC, Cameron, MINT, UK, o'neill, oneill, resistance

The UK Government has pledged to become a world leader in tackling antibiotic resistance in the face of a medical …
Amgen image

FDA breakthrough for Amgen

July 2, 2014 Research and Development, Sales and Marketing Amgen, BiTE antibody blinatumomab, FDA, all, leukaemia

Amgen has taken a major step down the road to getting its investigational cancer drug blinatumomab onto the market after …
The Gateway to Local Adoption Series

Latest content